. There are several key insights and financial metrics that can be extracted from this conference call transcript to support an 'overweight' investment stance. The company's organic sales were up about 2%, with developing and emerging markets delivering 4% organic sales growth. The company's market shares remain healthy and are holding up well in a competitive environment. Innovation continues to be an important part of the company's growth plans, with a number of launches planned in developing and emerging markets in diapers, diaper pants, feminine care, and adult care. The company expects organic sales growth to be higher in the second half of 2017 compared to the first half of the year. The company's bottom line is targeted to achieve earnings per share of $6.20 to $6.35, up 3% to 5% compared to adjusted results in 2016. Additionally, the company expects to allocate between $2.2 billion and $2.4 billion to dividends and share repurchases in 2017, which is a higher amount than in 2016. The company's strong performance in cost savings, margins, cash flow, and return on invested capital, and continued focus on financial discipline, suggest that the company is well-positioned for long-term success and shareholder value creation. Overall, the company's outlook for 2017 is positive, with a continued focus on executing global business plan strategies and managing the company with financial discipline. These key insights and financial metrics support an 'overweight' investment stance for the company.